ArticleAlzheimer's & dementia (New York, N. Y.)

Understanding the impact of amyloid beta targeted therapies on biomarkers and clinical endpoints in Alzheimer's disease.

Ronald C Petersen et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.